Long-term studies are still needed to fully understand the risks and benefits of using GLP-1 drugs in addiction treatment
This precision approach transforms weight loss from a one-size-fits-all intervention into a truly personalized metabolic strategy grounded in your genetic predispositions
And shell be watching to see how the legal fight influences public trust and the market for such drugs while raising larger questions about what level of drug risk warnings are deemed sufficient
During periods when people were taking semaglutide, the need for such care dropped by 42% compared to periods without GLP-1 use
Effects on quality of life, major adverse CV events & mortality are likely limited or uncertain. November 2025 Pdf of factsheet : Semaglutide binds to, and activates, the GLP-1 (glucagon-like peptide-1) receptor to increase insulin secretion, suppress glucagon secretion, and slow gastric emptying
There's no reason you can have the same transformation